The company was founded in March 2002, headquartered in Nanjing, and listed on the main board of the Shanghai Stock Exchange in July 2017. The company has a perfect quality management system, strictly complies with the requirements of regulations issued by the State Drug Administration, and strictly implements foreign standards such as ISO13485 quality management system, Directive98/79EC, Regulation (EU) 2017/746, etc., and always checks the quality management of business processes. The company has focused on R&D, production, sales and service of in vitro diagnostic reagents and instruments for more than 20 years. The company's main products are Poct reagents, chemiluminescence reagents, 3 cardiovascular instruments; POCT instruments, biochemical instruments, chemiluminescence instruments, assembly line instruments, blood cell instruments, coagulation instruments, urine instruments, dry chemical instruments, molecular instruments, etc. Corporate honors: Enterprise honors Nanjing Enterprise Technology Center, advanced production units for in vitro diagnosis, key high-tech enterprises of the National Torch Program, etc.